Home › Funds › Novo Holdings A/S › CTNM

Novo Holdings A/S position in CTNM

CONTINEUM THERAPEUTICS INC · Health Care

Novo Holdings A/S reported holding 704,013 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 0.63% of its reported portfolio and ranking #22 among its reported holdings. Novo Holdings A/S first reported this position in Q3 2026.

Latest position (Q3 2026)704.01K sh
Reported value held$9.45M
Portfolio Weight0.63%
First reportedQ3 2026
Last changeNew
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Novo Holdings A/S's CTNM position evolved

Novo Holdings A/S first disclosed a stake in CTNM in Q3 2026 at 704,013 shares (US$9.4M).

Quarter by quarter

QuarterSharesValueChange
Q3 2026 704.01K $9.45M New

About CTNM and 13F data

CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$37.8M), JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTNM

All CTNM fund holders →

FAQ

How long has Novo Holdings A/S held CTNM?

Novo Holdings A/S has disclosed CTNM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Novo Holdings A/S's current position in CTNM?

As of Q3 2026, Novo Holdings A/S holds 704.01K shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $9.45M, representing 0.63% of its reported portfolio and ranking #22.

Has Novo Holdings A/S been buying or selling CTNM?

In the latest 13F filing (Q3 2026), Novo Holdings A/S newly opened its position in CTNM.

Which other funds hold CTNM?

Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.